English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17776/20117 (88%)
Visitors : 10959275      Online Users : 546
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/32320

    標題: Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
    作者: Jean, Shio-Shin
    Lee, Nan-Yao
    Tang, Hung-Jen
    Lu, Min-Chi
    Ko, Wen-Chien
    Hsueh, Po-Ren
    貢獻者: Taipei Med Univ, Dept Emergency, Sch Med, Coll Med
    Taipei Med Univ, Dept Emergency Med, Wan Fang Hosp
    Taipei Med Univ, Dept Emergency & Crit Care Med, Wan Fang Hosp
    Natl Cheng Kung Univ, Dept Internal Med, Med Coll & Hosp
    Chi Mei Med Ctr, Dept Med
    Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
    China Med Univ, Dept Microbiol & Immunol, Sch Med
    Natl Taiwan Univ, Dept Lab Med, Natl Taiwan Univ Hosp, Coll Med
    Natl Taiwan Univ, Dept Internal Med, Natl Taiwan Univ Hosp, Coll Med
    關鍵字: carbapenem-resistant Enterobacteriaceae
    Klebsiella pneumoniae
    Escherichia coli
    long-term care facility
    日期: 2018-11-27
    上傳時間: 2019-12-16 09:35:31 (UTC+8)
    摘要: Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control. Many investigations have shown a high association of CRE infections with high case-fatality rates. In Taiwan, a few surveys observed that a significant proportion (29-47%) of the CR-Klebsiella pneumoniae isolates harbored a plasmidic allele encoding K. pneumoniae carbapenemases (KPC, especially KPC-2). A significant increase in the number of oxacillinase (OXA)-48-like carbapenemases among CR-K. pneumoniae isolates was observed between 2012 and 2015. By striking contrast, isolates of CR-Escherichia coli and CR-Enterobacter species in Taiwan had a much lower percentage of carbapenemase production than CR-K. pneumoniae isolates. This differs from isolates found in China as well as in the India subcontinent. Apart from the hospital setting, CRE was also cultured from the inpatients from communities or long-term care facilities (LTCF). Therefore, implementation of regular CRE screening of LTCF residents, strict disinfectant use in nursing homes and hospital settings, and appropriate control of antibiotic prescriptions is suggested to alleviate the spread of clinical CRE isolates in Taiwan. Although there are some promising new antibiotics against CRE, such as ceftazidime-avibactam, meropenem-vaborbactam, aztreonam-avibactam and cefiderocol, these agents are not available in Taiwan currently. Therefore, in order to effectively decrease case-fatality rates among patients with the infections owing to carbapenemase-producing CRE isolates, combination antibiotic schemes, including colistin (or amikacin) and/or tigecycline in combination with an anti-pseudomonal carbapenem agent, remain the mainstay for treating clinical CRE infections.
    link: http://dx.doi.org/10.3389/fmicb.2018.02888
    關聯: Nova Hedwigia, v.9, 2888
    Appears in Collections:[保健營養系(所) ] 期刊論文

    Files in This Item:

    File Description SizeFormat
    10.3389-fmicb.2018.02888.pdf492KbAdobe PDF96View/Open

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback